Find Academic Supervisors

Dr. Shubham Misra is a Research Fellow in the Department of Neurology at Yale University School of Medicine. He holds a Ph.D. in Neurology from the All India Institute of Medical Sciences (2022) and advanced degrees in Biotechnology from Amity University (2014). His research focuses on biomarker discovery, proteomics, and clinical data analysis in neurological disorders, particularly stroke and post-stroke epilepsy. Dr. Misra has authored over 50 peer-reviewed publications, including work in JAMA Neurology and Neurology , and leads research on omics-based approaches in stroke at Frontiers in Neurology. He collaborates globally, including with the WHO's Brain Health Unit to address neurological aspects of pandemics like COVID-19. Research Interests: Biomarker discovery using proteomics and machine learning, outcomes research in stroke, genetic risk factors for neurological disorders, and systematic reviews/meta-analyses. Dr. Misra's work bridges clinical neurology with advanced data science, aiming to improve diagnostics and patient outcomes. Awards: Young Investigator Award (World Stroke Organization), DST-INSPIRE Fellowship (India), and multiple international travel grants for collaborative research. Grants & Collaborations: Leads the International Post-stroke Epilepsy Research Repository (IPSERR) and collaborates with institutions worldwide. His work on post-stroke epilepsy and stroke subtyping biomarkers has been widely cited (over 1,200 citations). Labs & Teams: Mishra Lab at Yale, Rangaraju Lab, and global networks through the WHO's Global Forum and IPSERR consortium.

• Biomarkers
• Stroke Research
• Proteomics
• +7 more

Zion Zibly, MD, MBA is an Associate Professor in the Department of Neurosurgery at Yale School of Medicine . He holds multiple leadership roles including Director of the Center of Neuromodulation , Director of the Center of Neurosurgical Cancer Pain , and Head of Stereotactic & Functional Neurosurgery and the Focused Ultrasound Institute . Previously served as Chair of Neurosurgery at Sheba Medical Center after graduating from Technion’s Faculty of Medicine (MD) and Coller School of Management (MBA). Research Interests: Specializes in Neuromodulation for movement disorders (Parkinson’s, tremors, dystonia), Deep Brain Stimulation , Gene Therapy for pediatric neurodegenerative conditions, Oncological Neurosurgery , and Neurological Pain Management . Combines Functional Neurosurgery with Focused Ultrasound technology. Scientific Contributions: Participated in pioneering Alzheimer’s brain stimulator procedures and Gene Therapy applications. Active member of the North American Association of Functional Neurosurgery and Israeli Neurosurgical Society . Clinical Expertise: Implantation of electrostimulators for Parkinson’s and essential tremor, treatment of Benign/Malignant CNS Tumors , and management of Neurological Pain Conditions . Affiliated with Yale Cancer Center and Center for Brain & Mind Health .

• Neurosurgery
• Functional Neurosurgery
• Neuromodulation
• +3 more

Istvan Mody is a Professor at the University of California, Los Angeles (UCLA) with appointments in the Department of Neurology and Department of Physiology . His research focuses on synaptic signaling in health and disease, including mechanisms of GABAergic transmission, calcium homeostasis, and their roles in neurological disorders such as epilepsy, Alzheimer's disease, Huntington's disease, stress, alcoholism, and postpartum depression. He utilizes advanced techniques like patch-clamp electrophysiology, neuroanatomical and immunohistochemical methods, and molecular biology in animal models and human brain tissue . Research Interests: Dr. Mody investigates the physiology, pharmacology, and pathology of synaptic transmission and extrasynaptic receptor activation , with a particular emphasis on GABA(A) receptors and their subunit-specific modulation. His work explores how disruptions in excitation-inhibition balance contribute to neurological diseases, including mechanisms of tonic inhibition , calcium signaling , and neurosteroid interactions . He also studies the effects of chronic stress and hormonal fluctuations on neural excitability and behavior. Publications Trends: Recent studies highlight his work on gamma oscillations in Alzheimer's models, microglial dynamics , and rehabilitation strategies for stroke. His lab develops optical tools like dqGEVI for neuronal activity monitoring and investigates human brain organoids to model network dysfunction in epilepsy and intellectual disability. Laboratory Location: 635 Charles Young Dr S, Los Angeles, CA 90095, United States.

• Neuroscience
• Neurology
• Pharmacology
• +12 more

Chandan J Vaidya is a Professor in the Department of Psychology at Georgetown University, directing the Developmental Cognitive Neuroscience Laboratory (DCNL). His research focuses on cognitive neuroscience mechanisms underlying adaptive behaviors, particularly implicit learning, executive control, and their dysfunction in ADHD, ASD, and other developmental disorders. Using multidisciplinary methods including fMRI, behavioral testing, and genetic analysis, he investigates how dopamine systems, brain connectivity, and environmental factors influence cognitive processes. Primary appointment: Professor, College of Arts and Sciences - Department of Psychology Education: Ph.D. from Syracuse University Research interests include neurodevelopmental disorders, neuroimaging of cognitive control, and translational neuroscience. Recent work examines striatal connectivity changes in ADHD due to stimulant use, executive dysfunction subtypes in autism, and brain correlates of reward processing in obesity. Key findings highlight hyperconnectivity in ASD, dopamine genotype influences on executive function, and age-related changes in default mode networks. Ongoing studies explore transdiagnostic models of psychopathology and precision medicine approaches in neurodevelopmental disorders. Lab activities focus on translational research bridging basic neuroscience with clinical applications. Collaborations involve pediatric neurology, psychiatry, and computational modeling.

• Cognitive Neuroscience
• Developmental Disorders
• ADHD
• +5 more

Scott Michael Lindhorst, MD, is an Assistant Professor in the Department of Neurosurgery at the Medical University of South Carolina (MUSC) College of Medicine. He holds a dual appointment in the Division of Hematology/Medical Oncology within the Department of Medicine. Dr. Lindhorst specializes in neuro-oncology, focusing on central nervous system lymphomas, gliomas, and meningiomas, while also managing brain metastases through clinical trials. Education: BS in Microbiology from University of Florida (2001), MD from University of South Alabama College of Medicine (2005) Training: Residency in Internal Medicine, Fellowship in Hematology/Medical Oncology (University of Alabama at Birmingham), Fellowship in Neuro-Oncology (Duke University Medical Center) His research centers on immuno-oncology , glioblastoma therapy , and epigenetic cancer treatments , with a strong emphasis on clinical trials for novel therapies. Recent publications explore hypermutation in cancer , immune checkpoint inhibition , and programmed necrosis in glioblastoma . Dr. Lindhorst is board-certified in internal medicine, hematology, medical oncology, and neuro-oncology. Clinical practice includes CNS lymphomas , gliomas , meningiomas , and brain metastases , with dedicated clinical trials to advance treatment options.

• Neuro-Oncology
• Medical Oncology
• Brain & Spine Tumors
• +2 more

Dr. Nika Danial is an Associate Professor of Cell Biology at Harvard Medical School and the Department of Cancer Biology at Dana-Farber Cancer Institute. She leads the Danial Lab, investigating metabolic mechanisms that regulate cellular adaptation to stress, with a focus on fuel utilization in health and disease. Dr. Danial holds additional roles as Co-Director of the NCI-funded T32 Training Program in Cancer Chemical Biology and Metabolism. Her research integrates biochemistry, mouse models, and metabolomics to study metabolic contributions to cancer, diabetes, and neurological disorders. Education: PhD from Columbia University (1999), postdoctoral training at Harvard Medical School and Dana-Farber under Dr. Stanley Korsmeyer. Key research areas include mitochondrial dynamics, glucose metabolism pathways, and the interplay between inflammation and metabolic signaling. The lab has pioneered studies on how metabolic flexibility impacts disease progression in pancreatic islets, lymphoma subtypes, and neuronal excitability. Publications highlight discoveries in mitochondrial fatty acid oxidation regulation, urea cycle anti-inflammatory mechanisms, and metabolic signatures in cancer subtypes. Her work has implications for developing therapies targeting metabolic vulnerabilities in diseases like diffuse large B-cell lymphoma and type 1 diabetes. The Danial Lab emphasizes rigorous training for the next generation of scientists through mentorship programs and interdisciplinary collaboration.

• Metabolic Biology
• Cancer Research
• Diabetes
• +4 more

Michael Harrison is an Assistant Professor in the Department of Cell and Developmental Biology at Weill Cornell Medicine, where he leads the Regeneration and Development Lab within the Graduate School of Medical Sciences. His research focuses on vascular development and regeneration using zebrafish as a model organism, with emphasis on coronary and cerebral vasculature. Education: B.Sc. in Genetics, University of Edinburgh (2005) Ph.D. in Developmental Genetics, University of Sheffield (mentor: Vincent Cunliffe) Postdoctoral Fellowship, Saban Research Institute, Children’s Hospital Los Angeles (CIRM Fellow) Harrison's research centers on understanding how blood and lymphatic vessels form and regenerate, particularly in the heart and brain. His lab investigates coronary vessel development, the role of lymphatic systems in inflammation and regeneration, and revascularization after injury. By leveraging zebrafish genetics and advanced imaging, his work aims to uncover pathways that could be harnessed for regenerative therapies in humans. His recent publications reveal key signaling mechanisms such as Cxcr4-Cxcl12 in coronary development and the two-step formation of cardiac lymphatics. The 15 most recent articles demonstrate a strong, consistent research trajectory in vascular biology and regeneration, with increasing use of advanced techniques like single-nuclei multiomics, fluidic imaging devices, and CRISPR-based genome editing. His work spans developmental mechanisms, functional imaging, and translational applications in cardiac repair. Scientific Awards: No awards explicitly mentioned in the provided text. Harrison actively mentors a team of postdoctoral fellows, research assistants, and students, several of whom have progressed to medical school or research careers. His lab collaborates extensively, particularly with Ching-Ling Lien's group. He has secured research space and funding to support ongoing projects in cardiac and cerebral vasculature. The lab is actively recruiting rotation students from BCMB, PBSB, IMP, and Tri-Institutional programs, as well as postdoctoral researchers and research assistants, indicating an expanding research team and active grant support. Labs and Teams: Regeneration and Development Lab, Weill Cornell Medicine Collaborations with Ching-Ling Lien Lab Member of Tri-Institutional PhD Programs Active participation in BCMB, PBSB, and IMP training programs

• Vascular Biology
• Regenerative Medicine
• Developmental Biology
• +11 more

Sai Zhang is an Assistant Professor in the Department of Epidemiology at the University of Florida (UF), holding affiliations with the College of Public Health & Health Professions and College of Medicine. He is also an Affiliate Faculty in the J. Crayton Pruitt Family Department of Biomedical Engineering at the Herbert Wertheim College of Engineering. Previously, he was an Instructor at Stanford University School of Medicine and a Research Associate at the VA Palo Alto Epidemiology Research and Information Center (ERIC). Dr. Zhang completed his Ph.D. in Computer Science and Technology at Tsinghua University, followed by postdoctoral training in Dr. Michael Snyder’s lab at Stanford Genetics. His research integrates machine learning, genomics, and precision medicine to uncover genomic bases of complex diseases. Key focuses include developing algorithms for multiomic data analysis, modeling genotype-phenotype relationships, and leveraging deep learning for biological sequence analysis. His work emphasizes cell-type-specific mechanisms in diseases like ALS, coronary artery disease, and neurodegenerative disorders. Notable contributions include frameworks for polygenic risk scoring (e.g., PRS-Net), biomarker discovery for ALS, and tools for time-to-event prediction in neurological diseases. He leads the Zhang Laboratory, advancing computational systems for precision health applications.

• Machine Learning
• Genomics
• Precision Medicine
• +5 more

Saud Alhusaini MD PhD is an Assistant Professor of Neurology at the Warren Alpert Medical School of Brown University and serves as a Neurologist/Movement Disorders Specialist at Rhode Island Hospital. His research integrates imaging genomics and multimodal brain imaging approaches to investigate neurological disorders including Parkinson's disease, essential tremor, and epilepsy. He is affiliated with the Carney Institute for Brain Science and collaborates extensively with clinicians, geneticists, electrophysiologists, MRI specialists, neuropsychologists, and data scientists. Education: PhD from the Royal College of Surgeons in Ireland (RCSI) MSc in Neuroscience from Trinity College Dublin MD from University of Dublin, School of Medicine Adult neurology residency at McGill University/Montreal Neurological Institute Clinical research fellowship at Yale School of Medicine Clinical fellowship at Stanford University Medical Center Dr. Alhusaini's research focuses on identifying key endophenotypes and subclinical biomarkers to elucidate the underlying mechanisms of complex neurological conditions. His work spans multiple areas including movement disorders, epilepsy, and brain structure genetics. He has made significant contributions to understanding the genetic architecture of brain structures through his involvement with the ENIGMA consortium, which conducts large-scale collaborative analyses of neuroimaging and genetic data across institutions worldwide. An analysis of his publication record reveals a consistent pattern of high-impact research at the intersection of neurology, genetics, and advanced imaging techniques. His recent work demonstrates particular expertise in Parkinson's disease genetics, epilepsy network analysis, and movement disorder diagnostics. The breadth of his research, spanning from basic genetic mechanisms to clinical applications, highlights his comprehensive approach to understanding neurological disorders. Dr. Alhusaini has received funding from the Rhode Island Research Foundation, Brown Physicians, Inc., and Advance RI-CTR to support his research initiatives. His collaborative approach is evident through his numerous multi-institutional projects and extensive co-author network across Brown University departments including Neurology, Neurosurgery, and Pathology and Laboratory Medicine.

• Neurology
• Movement Disorders
• Parkinson's Disease
• +4 more

Sara Shostak is a Professor of Sociology and Health: Science, Society & Policy at Brandeis University, where she also serves as the inaugural director of the Vic '63 and Bobbi Samuels '63 Center for Community Partnerships and Civic Transformation (COMPACT). Her work bridges sociology, public health, and environmental studies, focusing on health inequalities, urban agriculture, and community partnerships. She holds affiliations across multiple departments including the Heller School for Social Policy and Management, Women’s, Gender, and Sexuality Studies, and Environmental Studies. Shostak earned a Ph.D. from the University of California, San Francisco, an M.P.H. from UCLA, and a B.A. from Reed College. Her research emphasizes interdisciplinary approaches to understanding how social structures and environmental factors shape health outcomes, particularly through projects involving marginalized communities and stakeholders like farmers, healthcare providers, and policymakers. Her research interests include medical sociology, science and technology studies, environmental racism, and food justice. She has pioneered studies on urban agriculture’s role in addressing health inequities and explored ethical dimensions of genetic testing in epilepsy families. Her work often integrates community engagement and participatory methods to ensure research impacts policy and practice. Awarded the Eliot Freidson Outstanding Publication Award and the Robert K. Merton Book Award, Shostak has secured grants from the National Science Foundation, Robert Wood Johnson Foundation, and Merck Family Fund. Her teaching innovations have been recognized with the Michael L. Walzer '56 Award for Teaching. She leads COMPACT to foster civic engagement and partnerships between Brandeis and local communities, emphasizing transformative change through collective action.

• Medical Sociology
• Science and Technology Studies
• Environmental Sociology
• +4 more

Irina A. Anselm, MD is Assistant Professor of Neurology at Harvard Medical School and Director of the Mitochondrial Program at Boston Children's Hospital. She co-directs the Neurometabolic Program and serves as clinical expert for the hospital's Precision Medicine Service. Her work spans pediatric neurology , neurogenetics , and mitochondrial medicine . Medical School: St. Petersburg Pediatric Medical Academy (1984) Residency: University of Massachusetts Medical Center (1995) Fellowship: New England Medical Center (1998) Dr. Anselm specializes in mitochondrial disorders and neurometabolic syndromes affecting children. Her research focuses on genetic diagnosis , experimental therapies , and clinical management of these complex conditions. She leads clinical trials evaluating novel treatments like dichloroacetate (DCA) for lactic acidemia and collaborates with biotech companies on gene therapy approaches. Key publication areas include mitochondrial disease pathophysiology , neurodevelopmental genetic mutations , and experimental treatment outcomes . She has authored consensus guidelines for mitochondrial disease management and serves as reviewer for multiple journals including Journal of Pediatric Neurology and Current Pediatric Reviews .

• Genetics
• Neurology
• Metabolic Disorders
• +5 more

Dr. Barbara L. Hempstead is a Professor of Neuroscience and Medicine at Weill Cornell Medical College, where she has held positions since 2001 and 2002 respectively. Her research focuses on neurotrophin signaling mechanisms, particularly the roles of BDNF and its receptors in neuroinflammation, synaptic plasticity, and neurodegenerative diseases. She has made significant contributions to understanding proBDNF/proNGF signaling pathways in neuronal apoptosis and vascular biology. Education: M.D., Ph.D., Washington University School of Medicine (1982) B.A., Tufts University (1976) Dr. Hempstead's work bridges molecular neuroscience and cardiovascular biology, with a particular interest in receptor stoichiometry (p75NTR, TrkB), neurotrophin-induced synaptic remodeling, and therapeutic applications of neurotrophin modulators in Huntington's disease and post-seizure neuronal injury. Her lab investigates how genetic variants like BDNF Val66Met influence anxiety-related behaviors, social memory, and neurodegenerative disease progression through altered neurotrophin trafficking and signaling. Her recent publications highlight neuroinflammatory mechanisms (2023), immune-neurotrophin interactions (2022), and molecular pathways involving BDNF prodomain structure (2020) and SorCS2-mediated receptor trafficking (2017-2020). While no scientific awards are explicitly mentioned in the scraped text, her funded research (National Institute on Aging, NIMH) demonstrates sustained recognition of her work in neurotrophin biology. Dr. Hempstead's lab develops in vitro and in vivo models to study neurotrophin-receptor dynamics, including 3D culture systems for angiogenesis research and transgenic mouse models for Huntington's disease. Her interdisciplinary approach combines molecular neurobiology with vascular physiology to uncover novel therapeutic targets for neurological and cardiovascular conditions.

• Neuroscience
• Neurotrophin Signaling
• Neurodegenerative Diseases
• +5 more

Mikail Rubinov serves as Assistant Professor of Biomedical Engineering (primary appointment), Computer Science, Psychiatry, and Psychology at Vanderbilt University's School of Engineering. His interdisciplinary work bridges computational neuroscience, network science, and clinical applications. His research focuses on integrative statistical models of large-scale neural data , exploring brain network organization across species and scales. Key interests include evolutionary principles of brain networks, transcriptomic basis of neural individuality, information transfer in neural systems, and neuropsychiatric connectivity phenotypes. The Rubinov Lab develops computational frameworks for analyzing complex neural systems and integrates neuroscientific knowledge with multi-omics data. Recent publications reveal strong trends in network neuroscience methodology development (circular analysis frameworks, unbiased sampling techniques) and translational applications (epilepsy networks, autism spectrum connectomics, gut-brain axis interrogation). His work increasingly incorporates transcriptomic data with neuroimaging at biobank scale. NIH Grant Writing Workshop (June 2022) NIH Workshop Short Talks (April 2023) Rubinov actively mentors graduate and undergraduate students across Biomedical Engineering and Computer Science. His lab maintains collaborations with UCSF, HHMI Janelia Research Campus, Weizmann Institute, and international neuroscience consortia. Current projects include integrative models of large-scale neural data and transcriptomic basis of neural individuality. The Rubinov Lab operates within Vanderbilt's Department of Biomedical Engineering with extensive cross-school collaborations. Technical resources include GitHub repositories for constraint network models (cnm-code), volumetric segmentation (voluseg), and brain connectivity toolboxes.

• Network Neuroscience
• Computational Neuroscience
• Brain Connectivity
• +4 more

Professor Jianmin Cui is a faculty member in the Department of Biomedical Engineering at Washington University in St. Louis, part of the McKelvey School of Engineering. His research focuses on the molecular basis of electrical signaling in cardiovascular and nervous systems, particularly ion channel dysfunction in diseases like cardiac arrhythmia and epilepsy. He designs small molecules and natural toxins targeting ion channels for therapeutic applications. Education: PhD, State University of New York, 1992 MS, Peking University, 1986 BS, Peking University, 1983 Research Interests: Professor Cui employs experimental and computational methods—including molecular biology, electrophysiology, and kinetic modeling—to study ion channel mechanisms. His lab investigates drug delivery protocols using ultrasound and explores electro-mechanical coupling in cardiac and neuronal systems. Recent work includes NIH-funded studies on potassium channelopathies and epilepsy mechanisms. Affiliations: Cardiac Bioelectricity & Arrhythmia Center Division of Biology & Biomedical Sciences Grants & Collaborations: Notable projects include NIH grants targeting potassium channel research and drug development for arrhythmias. Collaborations emphasize translational applications of ion channel discoveries. Labs & Teams: The Cui Lab integrates interdisciplinary approaches to bridge basic science and clinical therapies, with a focus on ion channel pharmacology and disease modeling.

• Cardiac Arrhythmia
• Neurological Disorders (e.g., Epilepsy)
• Electrophysiology
• +3 more

Dr. Le Zhang is an Assistant Professor of Neurology and of Neuroscience at Yale University School of Medicine. She holds primary appointment in the Department of Neurology and secondary appointment in the Department of Neuroscience, with affiliations across multiple research centers including the Center for Brain & Mind Health, Hafler Lab, Interdepartmental Neuroscience Program, WHRY Pilot Project Program Investigators, Women's Health Research at Yale, Wu Tsai Institute, and Yale Combined Program in the Biological and Biomedical Sciences (BBS). Dr. Zhang received her educational training through: B.S. in Biological Science from Peking University (2004) Ph.D. in Molecular Biology and Biochemistry from the University of Hong Kong (2010) Postdoctoral Fellow at University of Pennsylvania School of Medicine (2011) Research Fellow at Harvard Medical School (2016) Dr. Zhang's research program focuses on immune responses of the central nervous system in neurodegenerative diseases. Her work integrates cutting-edge single cell technologies, human research and mouse genetics to elucidate the body-to-brain immune axis in both health and disease. She has made significant contributions to understanding neuroinflammation in Parkinson's disease, Alzheimer's disease, HIV-associated neurocognitive disorder, and Multiple sclerosis. Her laboratory employs advanced techniques including single-cell transcriptomics, proteomics, and computational approaches to unravel complex immune mechanisms in neurological disorders. An analysis of Dr. Zhang's recent publications (2022-2025) reveals a strong focus on neuroimmunology and single-cell analysis of neurological disorders. Her work spans Parkinson's disease, Alzheimer's disease, multiple sclerosis, and HIV-associated neurocognitive disorders, with particular emphasis on how immune cells interact with the central nervous system. The research employs cutting-edge single-cell technologies to create detailed cellular atlases of diseased brains, revealing novel immune mechanisms and potential therapeutic targets. Dr. Zhang has received several prestigious awards recognizing her research contributions: NIH Blueprint for Neuroscience Interoception Research Initiative Early-Stage Investigator Award (2023) NIH NIDA's Avenir Award (DP2) (2022) Yale Alzheimer's Disease Research Center (ADRC) Research Scholar Award (2021) Kavli Institute for Neuroscience Innovative Research Award (2019) Dr. Zhang serves as Principal Investigator of the Zhang Lab, which focuses on understanding the immune network of the central nervous system. Her laboratory is actively recruiting highly motivated scientists to work on neuroimmunology and technology development. She has been involved in significant research initiatives including the SCORCH consortium for studying single-cell opioid responses in the context of HIV. Dr. Zhang previously served on the Yale School of Medicine Faculty Advisory Council from 2018-2023. Dr. Zhang's work has important implications for developing new therapeutic approaches for neurodegenerative diseases by targeting the immune system. Her research on the gut-brain axis and body-to-brain immune communication represents a paradigm shift in understanding how peripheral immune responses influence neurological health and disease.

• Neuroimmunology
• Neurodegenerative diseases
• Central nervous system immune responses
• +7 more